Sutro Biopharma, Inc. - Common Stock, par value $0.001 per share (STRO)
CUSIP: 869367102
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 16,182,923
- Total 13F shares
- 62,516,525
- Share change
- -607,344
- Total reported value
- $216,373,636
- Put/Call ratio
- 41%
- Price per share
- $3.46
- Number of holders
- 130
- Value change
- -$1,660,759
- Number of buys
- 71
- Number of sells
- 42
Quarterly Holders Quick Answers
What is CUSIP 869367102?
CUSIP 869367102 identifies STRO - Sutro Biopharma, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 869367102:
Top shareholders of STRO - Sutro Biopharma, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
48%
|
7,708,690
|
$22,586,462 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
43%
|
6,910,730
|
$20,248,438 | — | 30 Jun 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
27%
|
4,447,634
|
$13,031,567 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
27%
|
4,361,893
|
$12,780,346 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
22%
|
3,555,340
|
$10,417,147 | — | 30 Jun 2024 | |
| MPM BioImpact LLC |
13F
|
Company |
19%
|
3,043,346
|
$8,917,004 | — | 30 Jun 2024 | |
| Samsara BioCapital, LLC |
13F
|
Company |
14%
|
2,196,814
|
$6,436,665 | — | 30 Jun 2024 | |
| Kynam Capital Management, LP |
13F
|
Company |
13%
|
2,023,683
|
$5,929,391 | — | 30 Jun 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
12%
|
2,000,000
|
$5,860,000 | — | 30 Jun 2024 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
11%
|
1,848,751
|
$5,416,840 | — | 30 Jun 2024 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
11%
|
1,792,740
|
$5,252,728 | — | 30 Jun 2024 | |
| Eversept Partners, LP |
13F
|
Company |
11%
|
1,739,129
|
$5,095,648 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
11%
|
1,724,941
|
$5,054,956 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
10%
|
1,619,907
|
$4,746,328 | — | 30 Jun 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
9.7%
|
1,574,958
|
$4,613,000 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
9.7%
|
1,565,307
|
$4,586,350 | — | 30 Jun 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
6.7%
|
1,085,281
|
$3,179,853 | — | 30 Jun 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
6.5%
|
1,050,189
|
$3,077,054 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
6.5%
|
1,049,372
|
$3,074,661 | — | 30 Jun 2024 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
5.6%
|
907,503
|
$2,658,984 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
5.6%
|
905,443
|
$2,652,948 | — | 30 Jun 2024 | |
| Aquilo Capital Management, LLC |
13F
|
Company |
4.7%
|
762,498
|
$2,234,119 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
4.4%
|
719,497
|
$2,108,126 | — | 30 Jun 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
4.2%
|
686,500
|
$2,011,445 | — | 30 Jun 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
3.9%
|
634,200
|
$1,858,206 | — | 30 Jun 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
3.1%
|
503,603
|
$1,475,557 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
3.1%
|
502,648
|
$1,472,759 | — | 30 Jun 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
2%
|
329,579
|
$965,666 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.8%
|
287,810
|
$843,286 | — | 30 Jun 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.8%
|
283,516
|
$830,701 | — | 30 Jun 2024 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
1.7%
|
275,057
|
$805,917 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.7%
|
272,719
|
$799,067 | — | 30 Jun 2024 | |
| Fisher Asset Management, LLC |
13F
|
Company |
1.7%
|
271,337
|
$795,017 | — | 30 Jun 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
1.5%
|
235,397
|
$690,000 | — | 30 Jun 2024 | |
| LPL Financial LLC |
13F
|
Company |
1.4%
|
230,149
|
$674,337 | — | 30 Jun 2024 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
1.4%
|
225,367
|
$660,325 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1.3%
|
216,828
|
$635,306 | — | 30 Jun 2024 | |
| Tejara Capital Ltd |
13F
|
Company |
1.3%
|
203,145
|
$595,215 | — | 30 Jun 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
195,700
|
$573,401 | — | 30 Jun 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.1%
|
181,401
|
$531,505 | — | 30 Jun 2024 | |
| Trevor Hallam |
3/4/5
|
Pres. Rsrch & Cf. Sctific Ofcr |
—
mixed-class rows
|
107,868
mixed-class rows
|
$507,563 | — | 14 Apr 2023 | |
| STRS OHIO |
13F
|
Company |
1%
|
165,300
|
$484,329 | — | 30 Jun 2024 | |
| FMR LLC |
13F
|
Company |
0.94%
|
151,340
|
$443,427 | — | 30 Jun 2024 | |
| Man Group plc |
13F
|
Company |
0.81%
|
130,277
|
$381,712 | — | 30 Jun 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.8%
|
128,665
|
$376,988 | — | 30 Jun 2024 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.79%
|
128,231
|
$375,717 | — | 30 Jun 2024 | |
| Arturo Molina MD |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
127,236
mixed-class rows
|
$354,016 | — | 04 Mar 2022 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.72%
|
116,099
|
$340,160 | — | 30 Jun 2024 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.65%
|
105,310
|
$308,558 | — | 30 Jun 2024 | |
| Verition Fund Management LLC |
13F
|
Company |
0.6%
|
97,888
|
$286,812 | — | 30 Jun 2024 |
Institutional Holders of Sutro Biopharma, Inc. - Common Stock, par value $0.001 per share (STRO) as of Q3 2024
As of 30 Sep 2024,
Sutro Biopharma, Inc. - Common Stock, par value $0.001 per share (STRO) was held by
130 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
62,516,525 shares.
The largest 10 holders included
SUVRETTA CAPITAL MANAGEMENT, LLC, BlackRock, Inc., VANGUARD GROUP INC, Point72 Asset Management, L.P., MPM BIOIMPACT LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Samsara BioCapital, LLC, CITADEL ADVISORS LLC, Kynam Capital Management, LP, and MILLENNIUM MANAGEMENT LLC.
This page lists
130
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
119
Q3 2024 holders
130
Holder diff
11
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.